Biotech Financial Model & Valuation (Pharma Financial Model)   Excel template (XLSX)
$110.00

Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Log in to unlock full preview.
Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Biotech Financial Model & Valuation (Pharma Financial Model) (Excel template (XLSX)) Preview Image
Arrow   Click main image to view in full screen.

Biotech Financial Model & Valuation (Pharma Financial Model) (Excel XLSX)

Excel (XLSX)

$110.00
Designed by an FMVA Certified professional, who has collaborated with over 40 startups and crafted more than 350 Forecasting and Valuation Models.
Add to Cart
  


Immediate download
Fully editable Excel
Free lifetime updates

BENEFITS OF THIS EXCEL DOCUMENT

  1. Comprehensive Valuation Analysis – Assess profitability with key metrics like NPV, IRR, and DCF to make informed investment decisions.
  2. Accurate Financial Forecasting – Get precise projections for up to 30 years, including R&D costs, revenue, and market penetration.
  3. Flexible & Investor-Ready Model – Easily adapt the model to different monetization strategies and generate reports for investors.

HEALTHCARE EXCEL DESCRIPTION

This product (Biotech Financial Model & Valuation [Pharma Financial Model]) is an Excel template (XLSX), which you can download immediately upon purchase.

Download Biotech or Pharma Financial Model Template To Reach Full Potential of Your Biotech Venture

Our Biotech & Pharma Financial Model Template is an advanced, user-friendly tool designed to help industry professionals, entrepreneurs, and investors make data-driven decisions with confidence. This comprehensive Excel-based model offers in-depth financial forecasting for up to 30 years and supports up to 10 drug options, ensuring precise financial analysis at every stage of development.

1. Key Features: 1. Multi-Revenue & Monetization Strategies:

Forecast multiple revenue models including in-house production, licensing, royalties, and IP sales to explore different commercialization pathways and optimize returns.

Evaluate revenue potential and costs associated with each strategy to determine the most viable approach.

2. Dynamic & Customizable Financial Projections:
Built to handle various market scenarios, R&D timelines, production scales, and pricing models.

Fully adaptable with scenario analysis and stress testing to identify potential risks and opportunities.

Adjustable input drivers for development costs, sales forecasts, and market penetration rates.

3. Drug Profitability & Investment Analysis:
Analyze each of the 10 drug options separately, with detailed financial breakdowns for R&D investment, production costs, and profitability.

IRR & NPV calculations to assess the long-term financial viability of each drug.

Break-even analysis to determine the minimum sales volume needed for profitability.

4. Comprehensive Valuation Metrics & Sensitivity Analysis:
Discounted Cash Flow (DCF) analysis to accurately assess the overall valuation of the biotech/pharma business.

Multiples Valuations i.e. EV/ R&D expenses multiple, EV/ebitda and EV/Revenue multiples valaution.
Scenario-based valuation adjustments for different regulatory outcomes, market penetration, and funding requirements.

Sensitivity analysis to understand financial impact under various pricing, cost, and adoption rate scenarios.

5. Intuitive & User-Friendly Design:
Simple plug-and-play interface with pre-built formulas, ensuring ease of use.

Clearly defined input fields and automated calculations to minimize errors and save time.

Graphical representations and dashboards for quick insights and investor presentations.

Why Choose Our Model?
Expertly Designed: Developed by financial modeling professionals with extensive biotech and pharmaceutical industry experience.

Time-Saving & Accurate: Eliminates the need for complex manual calculations and provides real-time adjustments based on inputs.

Scalable & Flexible: Whether you're in early-stage drug discovery or scaling production, the model adapts to your needs.

Investor-Ready Reports: Generate financial projections and valuation summaries that align with investor expectations.

Free Custom Adjustments: Need small tweaks or fixes? We offer free modifications to ensure the model works seamlessly for your specific use case.

Who Can Benefit?
Biotech Startups & Pharma Companies looking to plan product commercialization and funding strategies.

Investors & Venture Capitalists assessing financial feasibility and risk profiles of biotech innovations.

CFOs & Financial Analysts seeking comprehensive valuation insights.

Business Consultants & Researchers needing structured financial forecasting tools.



With this powerful and dynamic financial model, you can strategically plan your biotech or pharma venture, make informed investment decisions, and optimize financial performance.

Take control of your financial future—download the Biotech & Pharma Financial Model Template today

Got a question about the product? Email us at support@flevy.com or ask the author directly by using the "Ask the Author a Question" form. If you cannot view the preview above this document description, go here to view the large preview instead.

Source: Best Practices in Healthcare, Integrated Financial Model Excel: Biotech Financial Model & Valuation (Pharma Financial Model) Excel (XLSX) Spreadsheet, Excel Business Resource


$110.00
Designed by an FMVA Certified professional, who has collaborated with over 40 startups and crafted more than 350 Forecasting and Valuation Models.
Add to Cart
  

ABOUT THE AUTHOR

Author image
Additional documents from author: 29

Excel Business Resource offers a leading-edge solution for streamlined financial modeling, budgeting, and reporting. Our customizable templates, curated by FP&A and FMVA experts, provide the foundation for precise, tailored financial analysis. From dynamic modeling to flexible budgeting and board-ready reports, our platform empowers informed decision-making for businesses of all sizes. ... [read more]

Ask the Author a Question

You must be logged in to contact the author.

Click here to log in Click here register

Did you know?
The average daily rate of a McKinsey consultant is $6,625 (not including expenses). The average price of a Flevy document is $65.




Trusted by over 10,000+ Client Organizations
Since 2012, we have provided best practices to over 10,000 businesses and organizations of all sizes, from startups and small businesses to the Fortune 100, in over 130 countries.
AT&T GE Cisco Intel IBM Coke Dell Toyota HP Nike Samsung Microsoft Astrazeneca JP Morgan KPMG Walgreens Walmart 3M Kaiser Oracle SAP Google E&Y Volvo Bosch Merck Fedex Shell Amgen Eli Lilly Roche AIG Abbott Amazon PwC T-Mobile Broadcom Bayer Pearson Titleist ConEd Pfizer NTT Data Schwab




Read Customer Testimonials

 
"As a small business owner, the resource material available from FlevyPro has proven to be invaluable. The ability to search for material on demand based our project events and client requirements was great for me and proved very beneficial to my clients. Importantly, being able to easily edit and tailor "

– Michael Duff, Managing Director at Change Strategy (UK)
 
"Flevy.com has proven to be an invaluable resource library to our Independent Management Consultancy, supporting and enabling us to better serve our enterprise clients.

The value derived from our [FlevyPro] subscription in terms of the business it has helped to gain far exceeds the investment made, making a subscription a no-brainer for any growing consultancy – or in-house strategy team."

– Dean Carlton, Chief Transformation Officer, Global Village Transformations Pty Ltd.
 
"I have used Flevy services for a number of years and have never, ever been disappointed. As a matter of fact, David and his team continue, time after time, to impress me with their willingness to assist and in the real sense of the word. I have concluded in fact "

– Roberto Pelliccia, Senior Executive in International Hospitality
 
"FlevyPro provides business frameworks from many of the global giants in management consulting that allow you to provide best in class solutions for your clients."

– David Harris, Managing Director at Futures Strategy
 
"[Flevy] produces some great work that has been/continues to be of immense help not only to myself, but as I seek to provide professional services to my clients, it gives me a large "tool box" of resources that are critical to provide them with the quality of service and outcomes they are expecting."

– Royston Knowles, Executive with 50+ Years of Board Level Experience
 
"FlevyPro has been a brilliant resource for me, as an independent growth consultant, to access a vast knowledge bank of presentations to support my work with clients. In terms of RoI, the value I received from the very first presentation I downloaded paid for my subscription many times over! The "

– Roderick Cameron, Founding Partner at SGFE Ltd
 
"If you are looking for great resources to save time with your business presentations, Flevy is truly a value-added resource. Flevy has done all the work for you and we will continue to utilize Flevy as a source to extract up-to-date information and data for our virtual and onsite presentations!"

– Debbi Saffo, President at The NiKhar Group
 
"I have used FlevyPro for several business applications. It is a great complement to working with expensive consultants. The quality and effectiveness of the tools are of the highest standards."

– Moritz Bernhoerster, Global Sourcing Director at Fortune 500


Your Recently Viewed Documents


Customers Also Like These Documents

Related Management Topics


Integrated Financial Model Healthcare Financial Analysis M&A (Mergers & Acquisitions)

Download our FREE Strategy & Transformation Framework Templates

Download our free compilation of 50+ Strategy & Transformation slides and templates. Frameworks include McKinsey 7-S Strategy Model, Balanced Scorecard, Disruptive Innovation, BCG Experience Curve, and many more.